MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...
MSD has expanded its presence in Ireland with an agreement to buy a vaccine manufacturing facility from Chinese biotech WuXi Biologics for around €500 million (around $520 million). The plant in ...
Mast cell activation disorders (MCAD) encompass a wide range of immune-mediated conditions characterized by episodic or chronic mast cell activation, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback